ALKERMES | ALKS - 流动资产

金融业

USD

USD 4.39B

现金及等价物

USD 511.53M

USD 120.7M

USD 1.52B

USD 662.09M

USD 1.58B

股息收益率

0

USD -65.93M

USD 139.22M

1.8K

EPS每股收益

USD 0

股本和储备

USD 1.81B

USD 375.31M

债务利息支出

USD 25.93M

USD 8.54M

USD 1.48B

USD 8.03B

USD 501K

USD 1.81B

USD -65.93M

普通股股本

USD 167.54M

135.81

USD -61.93M

USD 496.01M

销售和管理费用

USD 196.64M

USD 298.96M

贸易债权人

USD 142.86M

应收帐款人

USD 456.48M

	流动资产	更改		日
AbbVie	USD 33.67B		140M	2026-06
Acadia Pharmaceuticals	USD 1.22B		128.53M	2026-06
ALKERMES	USD 1.52B		164.26M	2026-06
Amgen	USD 34.96B		3.49B	2026-06
Biogen	USD 7.31B		1.88B	2026-06
BioMarin Pharmaceutical	USD 4.61B		651.58M	2026-03
Bristol-Myers Squibb	USD 28.58B		1.37B	2026-06
Coherus Biosciences	USD 133.79M		72.25M	2026-06
Eli Lilly	USD 64.67B		9.84B	2026-06
Gilead Sciences	USD 12.53B		6.11B	2026-06
Heron Therapeutics	USD 228.98M		9.08M	2026-03
Ionis Pharmaceuticals	USD 2.49B		446.73M	2026-06
J&J	USD 59.77B		601M	2026-06
Malin Corporation	EUR 62.6M		26.7M	2024-12
Merck	USD 35.02B		8.5B	2026-03
Minerva Neurosciences	USD 83.1M		70.08M	2025-12
Nektar Therapeutics	USD 589.04M		322.77M	2026-03
Neurocrine Biosciences	USD 1.64B		798.6M	2026-06
Otsuka Holdings	JPY 1.63T		30.58B	2026-06
Ovoca Bio	EUR 2.07M		510K	2025-12
Pfizer	USD 41.36B		1.46B	2026-06
Regeneron Pharmaceuticals	USD 18.45B		236.8M	2026-06
Vertex Pharmaceuticals	USD 12.54B		813.4M	2026-06